A Response to the Letter to the Editor: “Equipoise Is No Longer a Major Consideration in the Ethical Evaluation of Phase 3 Randomized Controlled Trials Involving Precision Oncology Approaches in NSCLC”

Saved in:
Bibliographic Details
Published inJournal of thoracic oncology Vol. 20; no. 4; p. e53
Main Authors Carlisle, Jennifer W., Pentz, Rebecca D., Ramalingam, Suresh S.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.04.2025
Online AccessGet full text
ISSN1556-0864
1556-1380
1556-1380
DOI10.1016/j.jtho.2025.01.025

Cover

Author Ramalingam, Suresh S.
Pentz, Rebecca D.
Carlisle, Jennifer W.
Author_xml – sequence: 1
  givenname: Jennifer W.
  surname: Carlisle
  fullname: Carlisle, Jennifer W.
  organization: Winship Cancer Institute of Emory University, Atlanta, Georgia
– sequence: 2
  givenname: Rebecca D.
  surname: Pentz
  fullname: Pentz, Rebecca D.
  organization: Winship Cancer Institute of Emory University, Atlanta, Georgia
– sequence: 3
  givenname: Suresh S.
  orcidid: 0000-0002-0757-3106
  surname: Ramalingam
  fullname: Ramalingam, Suresh S.
  email: ssramal@emory.edu
  organization: Department of Hematology–Oncology, Emory Winship Cancer Institute, Atlanta, Georgia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40204397$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1u1DAUxyNURD_gAiyQl2xmsOMk4yA2o2igI4W2KmVtufbLxKOMndrOSGXVg1CJs3AADtGT4ChTlqzes_z7PX_8T5MjYw0kyVuC5wST4sN2vg2tnac4zeeYzGN5kZyQPC9mhDJ8dOgxK7Lj5NT7LcZZjjP2KjnOcIozWi5Okj9LdA2-t8YDChaFFlANIYB7Xq2UDtZ9RE8PP1d3g-6tjuTaowuLams2ERToq9hah6o4RCtwImhrkDaTHlotRYdWe9EN045tfv-6akUcQ9G1MMru9A9Qox6c7brY3jgtOo_WZm-7vTYbdOVAaj_Kl0bazm7u0bLvnRWyBT8edfGtqqunh8fXycsmqvDmUM-S759XN9X5rL78sq6W9UxSXIaZIoTRnNI0x3nKYJGJUjS3hAoMpCQKGrWgkrCyyAVjESOSFEqmEAnABcnoWfJ-mhsvcTeAD3ynvYSuEwbs4DkljGUpW5RFRN8d0OF2B4r3Tu-Eu-fPGUQgnQDprPcOmn8IwXwMmm_5GDQfg-aY8Fii9GmSIL5yr8FxLzUYCUrHvwpcWf0__S-6b7TY
Cites_doi 10.1002/cncr.27397
10.1002/cncr.33746
ContentType Journal Article
Copyright 2025 International Association for the Study of Lung Cancer
Copyright_xml – notice: 2025 International Association for the Study of Lung Cancer
DBID AAYXX
CITATION
NPM
7X8
DOI 10.1016/j.jtho.2025.01.025
DatabaseName CrossRef
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1556-1380
EndPage e53
ExternalDocumentID 40204397
10_1016_j_jtho_2025_01_025
S1556086425000590
Genre Letter
Correspondence
GroupedDBID ---
.55
.XZ
.Z2
0R~
457
53G
5GY
5VS
AAEDW
AAKAS
AALRI
AAWTL
AAXUO
AAYWO
ABBUW
ABJNI
ABMAC
ABPMR
ACDDN
ACGFS
ACVFH
ACWDW
ACWRI
ADBBV
ADBIZ
ADCNI
ADEZE
ADVLN
ADZCM
AE3
AENEX
AEUPX
AEXQZ
AFETI
AFJKZ
AFPUW
AFTJW
AFTRI
AGCQF
AGHFR
AIGII
AITUG
AIZYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
BOYCO
C45
CS3
DU5
E.X
EBS
EJD
EX3
F5P
FDB
FL-
HZ~
IN~
KD2
NTWIH
O9-
OFXIZ
OGEVE
OK1
OVD
P2P
ROL
S4S
SSZ
TEORI
V2I
W3M
WOQ
WOW
X7M
AAYXX
CITATION
EFKBS
NPM
7X8
ID FETCH-LOGICAL-c309t-d1183533250528e74a9afb13a0e191defd73c18965a883321c16dc2e13ae06143
ISSN 1556-0864
1556-1380
IngestDate Fri Sep 05 17:41:29 EDT 2025
Mon Jul 21 05:15:10 EDT 2025
Tue Aug 05 12:01:57 EDT 2025
Sat Jul 05 17:12:14 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c309t-d1183533250528e74a9afb13a0e191defd73c18965a883321c16dc2e13ae06143
Notes content type line 23
SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
ORCID 0000-0002-0757-3106
PMID 40204397
PQID 3188428796
PQPubID 23479
ParticipantIDs proquest_miscellaneous_3188428796
pubmed_primary_40204397
crossref_primary_10_1016_j_jtho_2025_01_025
elsevier_sciencedirect_doi_10_1016_j_jtho_2025_01_025
PublicationCentury 2000
PublicationDate April 2025
2025-04-00
2025-Apr
20250401
PublicationDateYYYYMMDD 2025-04-01
PublicationDate_xml – month: 04
  year: 2025
  text: April 2025
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of thoracic oncology
PublicationTitleAlternate J Thorac Oncol
PublicationYear 2025
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Pentz, White, Harvey (bib1) 2012; 118
Abernethy, Campbell, Hianik (bib2) 2021; 127
Abernethy (10.1016/j.jtho.2025.01.025_bib2) 2021; 127
Pentz (10.1016/j.jtho.2025.01.025_bib1) 2012; 118
References_xml – volume: 118
  start-page: 4571
  year: 2012
  end-page: 4578
  ident: bib1
  article-title: Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trials
  publication-title: Cancer
– volume: 127
  start-page: 3794
  year: 2021
  end-page: 3800
  ident: bib2
  article-title: Reassessing the measurement and presence of therapeutic misconceptions in a phase 1 setting
  publication-title: Cancer
– volume: 118
  start-page: 4571
  year: 2012
  ident: 10.1016/j.jtho.2025.01.025_bib1
  article-title: Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trials
  publication-title: Cancer
  doi: 10.1002/cncr.27397
– volume: 127
  start-page: 3794
  year: 2021
  ident: 10.1016/j.jtho.2025.01.025_bib2
  article-title: Reassessing the measurement and presence of therapeutic misconceptions in a phase 1 setting
  publication-title: Cancer
  doi: 10.1002/cncr.33746
SSID ssj0045048
Score 2.4420774
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage e53
Title A Response to the Letter to the Editor: “Equipoise Is No Longer a Major Consideration in the Ethical Evaluation of Phase 3 Randomized Controlled Trials Involving Precision Oncology Approaches in NSCLC”
URI https://dx.doi.org/10.1016/j.jtho.2025.01.025
https://www.ncbi.nlm.nih.gov/pubmed/40204397
https://www.proquest.com/docview/3188428796
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1Lb9pAEMdXlEhVL1XfoS9No-ZkucJPcG8IESUNkIqAws1a22thROwUzCXfsP1UnX3ZtCVV2ouNLRvbmp93Z8f_mSXko5-6idWlqRmklm-6dsfj07y4pmsxxIUldurzROHR2D-duV_m3rzR-LGjWtqW0af4dm9eyf9YFfehXXmW7D9YtvpT3IG_0b64RAvj8l425lo2IXFl2oWU2Tl6a5BkPCSPg_5j2x5822Y3RYbHnmHbVhjDQmT8UmNEl8W6mrmT7qofhRqeVx6uaoILzdwCuz7DMSY0T4rr7JYHiaXifYU_p-LBeQGPYiWiFV_Xah4f4yKPZcmnnqpkLtRgxviyP-wfy8ThPY5yuUBM4yw2CnV6_d1kvco2Ug-tVTrGVd3Y52KuWk1QrW2e0GvKs_Dlu3C5XbPNQoWAVfzD9nZkM6rJlpUU5dcdtmefauft9g7P7k6jzWS54j86ExnXWOKDL3iaqK0KvHp116nlAuOL8GQ2HIbTwXz6gBzYHfTjmuSgdz65Otd-geu1xVxu1b2pFC6pNvz9Gne5SXcNg4Q7NH1CHivzQE9C-ZQ0WP6MPBwppcZz8r0Hmk0oC0CYQLKptySbn-Go4hLONjAuQHIJFASX8AuXkOXyZMkl1FxCkYLgEhyouYSaS5BcQsUlVFyC5hJqLvmVBJdHL8jsZDDtn5pq2hAzdtpBaSY4ZnZwFMOde7vLOi4NaBpZDm0zK7ASliYdJ7a6ge9RPtO2bcWWn8Q2wyMYj484L0kzL3J2SCByghRduCBy25Eb4NpDl9JzHd_nhddip0UMbaXwRlaHCbVschlym4bcpmHbCnHVIp42ZKj8W-m3hkjcX8_7oK0eYuPPv-jRnBXbTYgdcpfHPAK_RV5JHKr7cGXae-f1Pc5-Qx7Vr9Zb0izXW_YOne0yeq8o_gnDldji
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Response+to+the+Letter+to+the+Editor%3A+%22Equipoise+Is+No+Longer+a+Major+Consideration+in+the+Ethical+Evaluation+of+Phase+3+Randomized+Controlled+Trials+Involving+Precision+Oncology+Approaches+in+NSCLC%22&rft.jtitle=Journal+of+thoracic+oncology&rft.au=Carlisle%2C+Jennifer+W&rft.au=Pentz%2C+Rebecca+D&rft.au=Ramalingam%2C+Suresh+S&rft.date=2025-04-01&rft.issn=1556-1380&rft.eissn=1556-1380&rft.volume=20&rft.issue=4&rft.spage=e53&rft_id=info:doi/10.1016%2Fj.jtho.2025.01.025&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1556-0864&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1556-0864&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1556-0864&client=summon